Antihemophilic Factor (Recombinant)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAntihemophilic Factor (Recombinant)
Drug Alias Name้‡็ป„ๆŠ—่ก€ๅ‹็—…ๅ› ๅญEHL rFVIII PEG (Baxalta)Antihemophilic Factor้‡็ป„ๆŠ—่ก€ๅ‹็—…ๅ› ๅญVRecombinate
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factor
Mechanisms of ActionCoagulation factor VIII replacementsCoagulation factor X stimulantsBlood coagulation pathway activation
TargetsCoagulation factor X
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsHemophilia A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1992/12/10
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBaxalta Incorporated
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeB02BD02
Related LinksDrugBankKEGG